Quick Answer
Core Laboratories Inc. /DE/ reported Stockholders Equity of $265.99 million for the year ending 2025.
- Core Laboratories Inc. /DE/ showed an increase of +7.9% in Stockholders Equity from 2024 to 2025.
- This data is from Core Laboratories Inc. /DE/'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2023: $214.76 million | Q3 2023: $224.69 million | Q1 2024: $232.16 million | Q2 2024: $240.27 million | Q3 2024: $250.74 million | Q1 2025: $253.39 million | Q2 2025: $261.28 million | Q3 2025: $271.35 million.
- Over the full 4 years of available data (2022 to 2025), Core Laboratories Inc. /DE/'s Stockholders Equity has grown by 44.4%.
- Historical annual values: Fiscal year 2025: $265.99 million | Fiscal year 2024: $246.57 million | Fiscal year 2023: $224.82 million | Fiscal year 2022: $184.26 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: